CHM chimeric therapeutics limited
Add to My Watchlist 0.00% ! 0.4¢

Ann: Phase 1B CHM CORE-NK trial advances to newly diagnosed AML, page-17

  1. Shellbell
    8,329 Posts.
    lightbulb Created with Sketch. 3661
    clock Created with Sketch.
    17/12/24
    14:46
    Post #: 77088040
    It could open the door to other frontline combination therapies for CORE-NK beyond AML too.

    Positive prelim data from the CDH17 trial should be the catalyst for some serious SP accretion, don't you think?


    CHM Price at posting: 0.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS High-Grade Gold Hits Extend Major Lodes at Kpali Prospect in Ghana
right-arrow Created with Sketch.
NEWS Agreement for Sale of Mount Mason Project to Gold Valley Yilgarn
right-arrow Created with Sketch.
NEWS FBR Executes Engineering Service Agreement with Samsung Heavy Industries
right-arrow Created with Sketch.
NEWS Bonanza Dittmer Drilling Hits 221g/t Gold in Stage 5 Intersection
right-arrow Created with Sketch.
NEWS New Positive Interim Data in Phase 2 Study of SNT-5505 in Myelofibrosis
right-arrow Created with Sketch.
NEWS Pathological Complete Response Recorded in ACCENT Trial of Advanced Pancreatic Cancer
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $100 25K

Buyers (Bids)

No. Vol. Price($)
28 21874000 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 19510638 27
View Market Depth
Last trade - 15.25pm 17/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.